Related Experiment Video
Updated: May 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Observing the NICEties of hypertension management
E E Morrison1, E J Turtle, D J Webb
1Clinical Pharmacology and Therapeutics ST3, Royal Infirmary of Edinburgh, UK.
Insights
New UK hypertension guidelines shift first-line treatments from thiazide diuretics to calcium channel blockers or ACE inhibitors/ARBs. While aiming for cost-effectiveness, practical implementation and personalized care remain key considerations for managing high blood pressure.
Area of Science:
- Cardiology
- Clinical Practice Guidelines
- Pharmacotherapy
Background:
- The National Institute for Health and Clinical Excellence (NICE) recently updated UK hypertension management guidelines.
- Previous guidelines recommended thiazide diuretics as first-line therapy for hypertension.
- The updated guidelines introduce significant changes to the recommended therapeutic algorithm.
Purpose of the Study:
- To analyze the implications of the new NICE hypertension guidelines on UK clinical practice.
- To evaluate the proposed shift in first-line antihypertensive medications.
- To discuss potential challenges and considerations for implementing the updated guidance.
Main Methods:
- Review and analysis of the NICE clinical management of hypertension guidance.
- Comparison of previous and current treatment recommendations.
- Discussion of implementation challenges, including diagnostic methods and medication choices.
Main Results:
- The new guidelines prioritize calcium channel blockers (CCBs) and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) as initial treatments.
- Thiazide-like diuretics are now recommended as a third-line option.
- Chlortalidone replaces bendroflumethiazide, with potential issues regarding starting dose availability.
Conclusions:
- The guideline changes are based on cost-effectiveness and metabolic risk, but the rationale may require further robust validation.
- Ambulatory blood pressure monitoring, while logical, may pose a financial burden; home blood pressure measurement is suggested as a practical alternative.
- Effective hypertension management requires personalized treatment strategies, focusing on blood pressure reduction and lifetime risk assessment.
Abstract:
National Institute for Health and Clinical Excellence guidance for the clinical management of hypertension, published last year, proposes a step change in UK clinical practice.1 Although broadly helpful, there are some concerns about its implementation. Ambulatory blood pressure monitoring for diagnosis of hypertension, though logical, will place an additional financial burden on primary care at a time of austerity. Home blood pressure measurement may be a more practical option. Previous guidance recommended the used of thiazide diuretics as a first-line treatment option.2 Five years later, the new guidelines propose a major change, with an initial emphasis on the use of calcium channel blockers and angiotensin converting enzyme inhibitors/angiotensin receptor blockers, moving the use of thiazide-like diuretics to a third-line option. In addition, bendroflumethiazide, the mainstay of treatment in the UK over many years, has been replaced with chlortalidone, the starting doses of which are not readily available in this country. Cost-effectiveness analysis and a presumed risk of metabolic disorders has guided the rationale for these changes to the therapeutic algorithm, however this may not be robust. Importantly, unless there are special circumstances, reducing the blood pressure in hypertensive patients is more important than the means used to lower it. In future, it will be important to 'personalise' treatment more effectively and base management on lifetime risk.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Hypertension I: Introduction